Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Women are more likely to have long-term post-COVID symptoms than men.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

The treatment might help COVID-19 related hair loss, but more research is needed.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

New therapies are being developed that target integrin pathways to treat various diseases.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Skin can become dry and thick in hypothyroidism.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.

Low testosterone levels may lead to more severe COVID-19 outcomes.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

Cepharanthine could be a strong antiviral against COVID-19.

Women with high androgen levels may have more severe COVID-19 symptoms.